| Primary |
| Schizophrenia |
68.3% |
| Depression |
4.4% |
| Psychotic Disorder |
3.5% |
| Schizoaffective Disorder |
2.7% |
| Schizophrenia, Paranoid Type |
2.6% |
| Salivary Hypersecretion |
2.1% |
| Hypertension |
1.9% |
| Affective Disorder |
1.8% |
| Constipation |
1.8% |
| Anxiety |
1.7% |
| Diabetes Mellitus |
1.4% |
| Agitation |
1.0% |
| Epilepsy |
1.0% |
| Parkinson's Disease |
1.0% |
| Asthma |
0.9% |
| Bipolar Disorder |
0.8% |
| Insomnia |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Depressed Mood |
0.7% |
| Pain |
0.7% |
|
| Death |
19.1% |
| White Blood Cell Count Increased |
17.5% |
| White Blood Cell Count Decreased |
14.0% |
| Urinary Tract Infection |
4.8% |
| Vomiting |
4.6% |
| Tachycardia |
4.5% |
| Pneumonia |
3.2% |
| Weight Increased |
3.1% |
| Treatment Noncompliance |
3.0% |
| Schizophrenia |
2.7% |
| Platelet Count Decreased |
2.5% |
| Psychotic Disorder |
2.5% |
| Lower Respiratory Tract Infection |
2.5% |
| Neutrophil Count Decreased |
2.5% |
| Malaise |
2.4% |
| Myocardial Infarction |
2.4% |
| Somnolence |
2.3% |
| Mental Impairment |
2.2% |
| Neutrophil Count Increased |
2.1% |
| Mental Disorder |
2.1% |
|
| Secondary |
| Schizophrenia |
43.6% |
| Schizophrenia, Paranoid Type |
10.8% |
| Product Used For Unknown Indication |
7.9% |
| Depression |
5.7% |
| Schizophrenia, Disorganised Type |
3.9% |
| Psychotic Disorder |
3.5% |
| Constipation |
3.2% |
| Hypertension |
2.9% |
| Drug Use For Unknown Indication |
2.4% |
| Schizoaffective Disorder |
2.2% |
| Anxiety |
2.0% |
| Affective Disorder |
1.8% |
| Salivary Hypersecretion |
1.8% |
| Blood Cholesterol Increased |
1.6% |
| Insomnia |
1.3% |
| Depressed Mood |
1.3% |
| Agitation |
1.2% |
| Asthma |
1.2% |
| Type 2 Diabetes Mellitus |
1.1% |
| Parkinson's Disease |
0.9% |
|
| White Blood Cell Count Increased |
24.4% |
| White Blood Cell Count Decreased |
15.5% |
| Tachycardia |
8.2% |
| Vomiting |
5.6% |
| Treatment Noncompliance |
3.9% |
| Urinary Tract Infection |
3.5% |
| Somnolence |
3.2% |
| Schizophrenia |
3.2% |
| Platelet Count Decreased |
3.1% |
| Sedation |
2.9% |
| Weight Decreased |
2.9% |
| Overdose |
2.9% |
| Weight Increased |
2.8% |
| Death |
2.7% |
| Pneumonia |
2.7% |
| Neutropenia |
2.6% |
| Pyrexia |
2.6% |
| Urinary Incontinence |
2.5% |
| Psychotic Disorder |
2.4% |
| Syncope |
2.3% |
|
| Concomitant |
| Schizophrenia |
18.5% |
| Depression |
17.8% |
| Bipolar Disorder |
13.7% |
| Product Used For Unknown Indication |
9.7% |
| Anxiety |
7.0% |
| Sleep Disorder |
5.1% |
| Insomnia |
3.8% |
| Schizoaffective Disorder |
3.4% |
| Psychotic Disorder |
2.9% |
| Pain |
2.5% |
| Hypertension |
2.0% |
| Agitation |
1.9% |
| Post-traumatic Stress Disorder |
1.8% |
| Affective Disorder |
1.7% |
| Mental Disorder |
1.6% |
| Diabetes Mellitus |
1.5% |
| Blood Pressure |
1.4% |
| Schizophrenia, Paranoid Type |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
|
| Type 2 Diabetes Mellitus |
31.7% |
| Pancreatitis |
9.4% |
| Weight Increased |
7.7% |
| Diabetes Mellitus |
7.2% |
| Tardive Dyskinesia |
6.9% |
| White Blood Cell Count Increased |
5.8% |
| Vomiting |
3.6% |
| Diabetic Coma |
2.5% |
| Diabetic Ketoacidosis |
2.5% |
| Repetitive Speech |
2.4% |
| Type 1 Diabetes Mellitus |
2.4% |
| White Blood Cell Count Decreased |
2.4% |
| Death |
2.2% |
| Treatment Noncompliance |
2.2% |
| Psychotic Disorder |
2.0% |
| Overdose |
1.9% |
| Pneumonia |
1.9% |
| Urinary Incontinence |
1.9% |
| Obesity |
1.7% |
| Rash |
1.7% |
|
| Interacting |
| Schizophrenia |
33.4% |
| Convulsion |
8.1% |
| Obsessive-compulsive Disorder |
7.8% |
| Dyspepsia |
7.3% |
| Product Used For Unknown Indication |
6.7% |
| Depression |
6.4% |
| Constipation |
6.2% |
| Drug Use For Unknown Indication |
4.7% |
| Psychotic Disorder |
3.5% |
| Subcutaneous Abscess |
3.0% |
| Schizoaffective Disorder |
2.0% |
| Schizophrenia, Paranoid Type |
1.7% |
| Extrapyramidal Disorder |
1.3% |
| Affective Disorder |
1.2% |
| Hypertension |
1.2% |
| Lower Respiratory Tract Infection |
1.2% |
| Obesity |
1.2% |
| Abdominal Pain |
1.0% |
| Anaemia |
1.0% |
| Asthma |
1.0% |
|
| Repetitive Speech |
22.3% |
| Drug Toxicity |
13.3% |
| Vomiting |
7.2% |
| White Blood Cell Count Decreased |
5.4% |
| Drug Interaction |
4.8% |
| Syncope |
4.8% |
| Treatment Noncompliance |
4.8% |
| Weight Increased |
4.2% |
| Asthenia |
3.6% |
| Obsessive-compulsive Disorder |
3.6% |
| Sedation |
3.6% |
| Vertigo |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Rash |
3.0% |
| Terminal State |
2.4% |
| Toxicity To Various Agents |
2.4% |
| Blood Alkaline Phosphatase Increased |
1.8% |
| Heart Rate Increased |
1.8% |
| Hemiparesis |
1.8% |
| Loss Of Consciousness |
1.8% |
|
